CONMED Corp
CNMD · Electromedical & Electrotherapeutic Apparatus · 30.8M shares · +2%/yr ↑ shares · EDGAR filings ↗
Net buyback after stock comp: -$7M (gross $17M, SBC $24M)
Reference price $41.21 · est. market cap ~$1.3B — last insider sale, 2025-11-21 (estimated from the dated SEC Form 4 price × shares outstanding — not a live quote)
Grade
B70CONMED — surgical-device maker, profitable but earnings dented by charges.
Strengths
- ROA 84th pct, interest coverage 3.3x (89th), strong FCF (88th)
- Recurring single-use surgical-product demand
Risks
- Net income down 64% (20th pct) on charges
- Leverage and integration risk
- Competitive surgical markets
Notable findings
- Exec changeRecent 8-K item 5.02 8-K ↗
- Customer concentration~86% of revenue from one customer/distributor — These product lines as a percentage of consolidated net sales are as follows: 2025 2024 2023 Orthopedic surgery 42 % 42 % 43 % General surgery 58 58 57 Consolidated net sales 100 % 100 % 100
Quarterly revenue
Last 4 quarters · from SEC filings.
Key metrics
Gross margin
54.6%
Operating margin
7.5%
Net margin
3.4%
Return on equity
4.6%
Return on assets
2.0%
Revenue growth (QoQ)
10.4%
Net-income growth
-64.5%
Interest coverage
3.3×
Current ratio
2.1×
Free cash flow
$151M
Tangible book value
-$356M
Stock comp / revenue
2.1%
Insider transactions · last 18 months
| Date | Insider | Type | Shares | Price |
|---|---|---|---|---|
| 2026-06-02 | Bronson David M. | Option exercise | 668 | — |
| 2026-06-02 | Council LaVerne H | Option exercise | 668 | — |
| 2026-06-02 | Farkas Charles | Option exercise | 668 | — |
| 2026-06-02 | Kaye Mark | Option exercise | 668 | — |
| 2026-06-02 | Schwarzentraub Barbara J | Option exercise | 668 | — |
| 2026-03-06 | Lalomia Brent | Option exercise | 75 | — |
| 2026-03-06 | Lalomia Brent | Tax withheld | 26 | $39.90 |
| 2026-02-24 | Kaye Mark | Option exercise | 152 | — |
| 2025-11-21 | Glaze Richard | Sell | 257 | $41.21 |
| 2025-11-20 | Glaze Richard | Option exercise | 375 | — |
| 2025-11-20 | Glaze Richard | Tax withheld | 118 | $40.63 |
| 2025-11-06 | Garner Todd W | Sell | 3.5K | $43.00 |
| 2025-11-04 | Foust Hollie K | Option exercise | 4.0K | — |
| 2025-11-04 | Foust Hollie K | Tax withheld | 1.1K | $45.71 |
| 2025-10-31 | Garner Todd W | Option exercise | 7.5K | — |
| 2025-10-31 | Garner Todd W | Tax withheld | 2.2K | $44.00 |
| 2025-09-12 | Farkas Charles | Sell | 1.1K | $53.53 |
| 2025-09-12 | Farkas Charles | Sell | 897 | $53.51 |
| 2025-08-07 | Garner Todd W | Sell | 598 | $52.45 |
| 2025-06-03 | Schwarzentraub Barbara J | Option exercise | 479 | — |
| 2025-06-03 | Concannon Brian | Option exercise | 479 | — |
| 2025-06-03 | Farkas Charles | Option exercise | 479 | — |
| 2025-06-03 | Council LaVerne H | Option exercise | 479 | — |
| 2025-06-03 | Bronson David M. | Option exercise | 479 | — |
| 2025-06-03 | Aronson Martha Goldberg | Option exercise | 479 | — |
| 2025-05-29 | Farkas Charles | Option exercise | 1.0K | $55.70 |
| 2025-05-29 | Farkas Charles | Tax withheld | 966 | $57.69 |
| 2025-05-20 | Workman John L | Option exercise | 479 | $59.84 |
| 2025-05-05 | Farkas Charles | Sell | 4.0K | $56.94 |
| 2025-03-31 | Garner Todd W | Grant | 371 | $57.37 |
| 2025-03-14 | SHAGORY PETER K | Option exercise | 4.5K | $55.42 |
| 2025-03-14 | SHAGORY PETER K | Tax withheld | 4.3K | $58.83 |
| 2025-03-07 | Lalomia Brent | Option exercise | 75 | — |
| 2025-03-07 | Lalomia Brent | Tax withheld | 26 | $62.74 |
| 2025-02-11 | Glaze Richard | Sell | 257 | $65.35 |
All non-derivative Form 4 activity (SEC), newest first.
Supply chain
Customers (0)
Suppliers (2)
- Musculoskeletal Transplant Foundation
- W.L. Gore & Associates, Inc.
Named in the 10-K; linked when we track them.
Notable events (8-K)
| Date | Items | |
|---|---|---|
| 2026-06-17 | Exec/director changeReg FDExhibits | filing ↗ |
| 2026-06-04 | Material agreementExhibits | filing ↗ |
| 2026-06-01 | Material agreementDebt obligationExhibits | filing ↗ |
| 2026-05-20 | Exec/director change5.03Shareholder voteExhibits | filing ↗ |
| 2026-04-29 | ResultsExhibits | filing ↗ |
| 2026-03-13 | Exec/director change | filing ↗ |
| 2026-01-28 | ResultsExhibits | filing ↗ |
| 2026-01-12 | Reg FDExhibits | filing ↗ |
Recent filings
| Form | Filed | Period | Accession |
|---|---|---|---|
| 8-K | 2026-06-17 | 2026-06-17 | 0002077096-26-000203 ↗ |
| 8-K | 2026-06-04 | 2026-06-03 | 0001174947-26-000639 ↗ |
| 8-K | 2026-06-01 | 2026-05-27 | 0002077096-26-000190 ↗ |
| 8-K | 2026-05-20 | 2026-05-18 | 0000816956-26-000057 ↗ |
| 10-Q | 2026-04-30 | 2026-03-31 | 0000816956-26-000053 ↗ |
| 8-K | 2026-04-29 | 2026-04-29 | 0000816956-26-000051 ↗ |
| 8-K | 2026-03-13 | 2026-03-13 | 0001213900-26-027658 ↗ |
| 10-K | 2026-02-17 | 2025-12-31 | 0000816956-26-000009 ↗ |
| 8-K | 2026-01-28 | 2026-01-28 | 0000816956-26-000006 ↗ |
| 8-K | 2026-01-12 | 2026-01-12 | 0001174947-26-000024 ↗ |
| 8-K | 2026-01-08 | 2026-01-06 | 0001174947-26-000017 ↗ |
| 8-K | 2025-12-05 | 2025-12-05 | 0001213900-25-118476 ↗ |